Pills masthead

Fundamentals

Select the financial statements you wish to view below.  The reports below may be viewed on either an annual or quarterly basis.

NYSELCI
All numbers in thousands USD
Period Ending
Jun 30, 2022
Jun 30, 2021
Jun 30, 2020
Jun 30, 2019
Net Income
(231,620)
(363,475)
(33,366)
(272,107)
Operating Activities, Cash Flows Provided By or Used In
Depreciation
34,267
47,824
56,309
55,594
Changes In Accounts Receivables
42,593
26,854
39,064
84,949
Changes In Assets and Liabilities
29,053
(16,624)
38,701
73,430
Changes In Inventories
1,192
8,994
1,104
(2,336)
Changes In Other Operating Activities
117,390
357,278
14,202
236,780
Total Cash Flow From Operating Activities
(7,125)
60,851
116,014
176,310
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures
(10,489)
(14,915)
(47,130)
(27,340)
Investments
--
--
0
0
Other Cash flows from Investing Activities
12,564
114
7,130
20,050
Total Cash Flows From Investing Activities
2,075
(14,801)
(40,000)
(7,290)
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid
--
--
--
--
Sale/Purchase of Stock
(519)
(383)
(911)
588
Net Borrowings
0
(81,701)
(60,450)
(126,743)
Other Cash Flows from Financing Activities
0
(10,088)
(10,561)
(1,102)
Total Cash Flows From Financing Activities
(519)
(92,172)
(71,922)
(127,257)
Effect Of Exchange Rate Changes
137
79
(12)
(100)
Change In Cash and Cash Equivalents
(5,569)
(46,122)
4,092
41,763